Novo Nordisk shares rise after Wegovy obesity pill launch
A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, US, on Thursday, Jan.…
Language model-guided anticipation and discovery of mammalian metabolites
Training dataset A training dataset of known human metabolites was obtained from the HMDB, the largest and most…
Secretive Project Prometheus takes VC Bob Nelsen beyond just health care
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and…
Investor Noubar Afeyan warns against a backlash to science in the U.S.
SAN FRANCISCO — Noubar Afeyan, one of biotech’s top investors, warned in an annual letter that a backlash…
The golden age of vaccine development
In 1796, when Edward Jenner developed the first vaccine, against the smallpox virus, no one knew what viruses…
Childhood vaccine schedule slashed, ‘unknown risks’ of vaccination cited
WASHINGTON — Federal health officials are unilaterally reducing the number of recommended pediatric immunizations in response to an…
AtaiBeckley moves corporate domicile from Netherlands to Delaware
AtaiBeckley (NASDAQ: ATAI) completed the redomiciliation of its parent from a Netherlands company to a…
Opinion: The miracle of curing Alzheimer’s? No longer an impossibility. – MarketWatch
Opinion: The miracle of curing Alzheimer’s? No longer an impossibility. MarketWatchNew study shows Alzheimer’s disease can be reversed to…
U.S. vaccine policy could see big changes in 2026
WASHINGTON — Vaccine policy has become a key issue for the Trump administration, especially under the leadership of…
Pfizer, FDA, BioMarin, worst CEO of 2025: Readout Newsletter
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
Employers drop obesity drug coverage as cash-pay programs grow
When HCA Healthcare, one of the largest hospital systems in the U.S., recently told employees it would stop…
FDA voucher program has led to political interference in drug reviews, staffers say
WASHINGTON — A new program intended to fast-track drug reviews at the Food and Drug Administration is quickly…